Primary Laryngeal Amyloidosis and CO2 Laser as the Treatment Modality
Main Article Content
Abstract
Introduction
Amyloidosis is brought about by intracellular and/or extracellular accumulation of insoluble abnormal amyloid fibrils that alters the normal function of the tissues. Localized laryngeal amyloidosis is a rare disease which lacks long-term follow-up studies. It is prone to recurrence; hence meticulous excision is required. We are doing this study to analyse clinical features of primary laryngeal amyloidosis, the subsites commonly found in, and the effectiveness of CO2 laser as treatment modality.
Materials and Methods
It is a retrospective study of 13 patients diagnosed as Primary Laryngeal Amyloidosis in between 2005 to 2018, where clinical features, histologic and immuno-histochemical patterns of the patients were evaluated. Systemic amyloidosis was ruled out by the non-appearance of Bence-Jones proteins in urine and serum electrophoresis examination. Systemic workups were pursued during the follow-up. The patients were followed up 3 monthly for the first year, then 6 monthly after that, for 3 years. The last patient who underwent the surgery was in the 2018 and had just finished his 2nd follow up, while the rest have been followed up for 3 years.
Results
Hoarseness was the most common complaint in all the patients. The subsites most common for amyloid deposition were seen in the true vocal cords followed by supraglottis, anterior commissure, ventricle and the subglottis. Microscopically, the amyloid was deposited within the submucosa surrounded by lymphoplamocytic infiltration. All cases were treated with microlaryngoscopic CO2 Laser excision. With the exception of one patient, the rest had no recurrence.
Conclusion
Primary Laryngeal Amyloidosis is an uncommon benign disease that has a predisposition for recurrence. With use of CO2 laser as the primary treatment modality, the percentage of recurrence has drastically reduced. Systemic involvement should be ruled out. A frequent follow-up of the patients is desirable for early detection of recurrences. Laser is a novel treatment of laryngeal amyloidosis.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Behranwala KA, Ali Asgar B, Borges A. Laser in treatment of laryngeal amyloidosis. Indian J Otolaryngol Head Neck Surg. 2004;56(1): 46-8.doi: 10.1007/BF02968774
Muneeb A, Gupta S. Isolated Laryngeal Amyloidosis Mimicking Laryngeal Cancer. Cureus 2018;10(8):e3106
Finn DG, Farmer Jr JC. Management of amyloidosis of the larynx and trachea. Archives of Otolaryngology 1982;108:456
Wadhwa A, Dabholkar YG, Bhatt BV, Saberwal A, Velankar HK. Primary diffuse laryngeal amyloidosis, a rare cause of hoarseness of voice. Int J Health Sci Res. 2019; 9(11):111-4
Anderson R, Parrish J. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983 220:524-7
Zeitels SM, Burns JA. Laser applications in laryngology: past, present, and future. Otolaryngol Clin North Am. 2006;39(1):159172
Pietruszewska W, Wągrowska-Danilewicz M, Klatka J. Amyloidosis of the head and neck: a clinicopathological study of cases with long-term follow-up. Arch Med Sci. 2014;10(4):846-52. doi:10.5114/aoms.2013.39206
Oguz H, Safak MA, Demirci M, Arslan N. Familial primary localized laryngeal amyloidosis in two sisters. Kulak Burum Bogaz Ihtis Derg. 2007, 17 (5): 283-6
Michaels L, Hyams VJ. Amyloid in localised deposits and plasmacytomas of the respiratory tract. J Pathol. 1979 May;128(1):29-38. doi: 10.1002/path.1711280106
Mittrani M, Biller HF. Laryngeal amyloidosis. Laryngoscope 1985; 95: 1346-7
Grammans K, Lubsen H. Clinical implications of laryngeal amyloidosis. J Laryngol Otol. 1985; 99: 617-23
Yiotakis I, Georgolios A, Manolopoulus L. Primary localized laryngeal amyloidosis presenting with hoarseness and dysphagia: a case report. J Med Case Rep. 2009; 3(1):1-5
Behnoud F, Baghbanian N. Isolated laryngeal amyloidosis. Iran J Otorhinolaryngol. 2013; 25: 49-52
Gilad R, Milillo P, Som PM. Severe diffuse systemic amyloidosis with involvement of the pharynx, larynx, and trachea: CT and MR findings. AJNR Am J Neuroradiol. 2007 Sep;28(8):1557-8. doi: 10.3174/ajnr.A0604
Meyers A. Complications of Carbon Dioxide laser of the larynx. Annals of Otology, Rhinology and Laryngology 1981; 90:132-4
Andrews Jr AH, Polanyi TG, Grybauokas VT. General and clinical considerations in laryngologic laser. Otolaryngologic Clinics of North America 1983; 16: 793-806
Absten GT. Physics of light and lasers. Obstet Gynecol Clin North Am. 1991 Sep;18(3):407-27
Mosely H, Oswal V. Laser biophysics. Principles and practice of lasers in otorhinolarngology and head and neck surgery. 2nd ed.: 7
Lewis JE, Olsen KD, Kurtin PJ, Kyle RA. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg. 1992;106:372-7
O’Halloran LR, Lusk RP. Amyloidosis of the larynx in a child. Ann Otol Rhinol Laryngol. 1994;108:339-40
Shawky AA, Khalil AKH. Design and Performance Analysis of Small-Scale Parabolic Trough Solar Collectors Using Sustainable Materials. Reference Module in Materials Science and Materials Engineering. Elsevier. 2018;1-9.